Pharmaceutical Executive December 9, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Peer Exchange: Technology’s Role in Achieving Greater DE&I in Clinical Trials

In this roundtable discussion, industry experts gathered to address the state of achieving greater diversity in clinical research. The group highlighted a variety of topics including current challenges they are seeing, the use of technology, and more.

Out-of-Pocket Costs for MS Medications Rise While They Drop for Other Neurologic Conditions

The out-of-pocket cost for MS disease-modifying therapies jump by 217% going from $750 per year in 2012 to $2,378 per year in 2021.

OpenAI Adds $200 Monthly ChatGPT Pro Subscription With New Model

OpenAI is introducing a higher-priced paid tier for its chatbot ChatGPT that includes unlimited access to its most powerful...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
How will CMS administer the IRA Medicare Drug Price Negotiation under Trump?
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
One Institution’s Evidence-Based Approach to Adopting Biosimilars

Share This Article